Objective: The purpose of the present study was to characterize prescription stimulant non-medical use (NMU) in adolescents between the ages of 13 and 18 years seeking treatment for substance use disorder (SUD) with the Comprehensive Health Assessment Tool for Teens (CHAT™). Method: Adolescents being evaluated for SUD treatment between Q1 2010 and Q3 2017 (n = 20,189) completed the CHAT™. Results: About 4.3% of the sample (N = 867) of adolescents in SUD treatment reported past 30-day prescription stimulant NMU. Compared to those without past 30-day prescription stimulant NMU, more reported a lifetime diagnosis of learning disorder or ADHD, more took medication for emotional, behavioral, or learning disorders, received past-month inpatient treatment, or were currently not enrolled in school. Prescription stimulants were most often taken orally for NMU, however, approximately half reported using alternate routes of administration, the most prominent of which was intranasal use. Conclusion: About 4.3% of adolescents in SUD treatment evaluation reported past 30-day prescription stimulant NMU. Greater percentages of lifetime learning disorder, medication use, past-month inpatient treatment, school unenrollment, and overall substance misuse were associated with prescription stimulant NMU, as were alternate routes of administration. These data reveal an ongoing, persistent level of past-30-day NMU of prescription stimulants among adolescents being evaluated for SUD treatment.

目的：本研究的目的是通过青少年综合健康评估工具 (CHAT™ ）。方法：在 2010 年第一季度至 2017 年第三季度（n  = 20,189）之间接受 SUD 治疗评估的青少年完成了 CHAT™。结果：大约 4.3% 的样本（N = 867) 接受 SUD 治疗的青少年报告了过去 30 天的处方兴奋剂 NMU。与过去 30 天没有服用兴奋剂 NMU 的人相比，更多的人报告终生被诊断为学习障碍或多动症，更多的人因情绪、行为或学习障碍服用药物，过去一个月接受过住院治疗，或者目前没有入学。处方兴奋剂最常用于 NMU 口服，然而，大约一半报告使用替代给药途径，其中最突出的是鼻内使用。结论：在 SUD 治疗评估中，大约 4.3% 的青少年报告了过去 30 天的处方兴奋剂 NMU。终生学习障碍、药物使用、过去一个月的住院治疗、学校退学和总体药物滥用与处方兴奋剂 NMU 以及其他给药途径有关。这些数据显示，在接受 SUD 治疗评估的青少年中，过去 30 天处方兴奋剂的 NMU 持续、持续水平。